4
Changes in Ownership
CYTOKINETICS INC Filed Acc 0001127602-24-020876
EVP Research & Development sold 7,300 shares at $57.02 ($416,246)
- EVP Research & Development acquired 5,300 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Malik Fady Ibraham · EVP Research & Development
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-07-23 | Sale : show line 1 in the form 10b5-1 | −2,000 | $57.02 | $114,040 | 129,004 | D |
| 2024-07-23 | Exercise or conversion : show line 2 in the form 10b5-1 | +5,300 | $7.96 | $42,188 | 134,304 | D |
| 2024-07-23 | Sale : show line 3 in the form 10b5-1 | −5,300 | $57.02 | $302,206 | 129,004 | D |
| Open-market sales · 7,300 sh · avg $57.02 · $416,246 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-07-23 | Exercise or conversion : show line 4 in the form 10b5-1 Non-Qualified Stock Option (Right to Buy) | −5,300 | 53,000 | D |
Loading xslF345X05/form4.xml…